A Review of the Complications of Endomyocardial Fibrosis along with Their Physiological Compromise
H Nabhani - Journal of Advances in Medicine and …, 2023 - research.send4journal.com
Endomyocardial fibrosis (EMF) is a cardiac condition characterized by the presence of
fibrous tissue in the myocardium and endocardium, resulting in restricted heart function. This …
fibrous tissue in the myocardium and endocardium, resulting in restricted heart function. This …
Complications of Endomyocardial fibrosis and their physiological compromise: A review
ND Lungu, A Dujawara - Current Problems in Cardiology, 2023 - Elsevier
Endomyocardial fibrosis (EMF) is an endemic idiopathic cardiomyopathy denoted by
restricted and fibrous myocardium and endocardium. Apical fibrosis may cause thickening of …
restricted and fibrous myocardium and endocardium. Apical fibrosis may cause thickening of …
Endomyocardial Fibrosis
LOS Rêgo, GS Vilas-Boas… - ABC Heart Fail …, 2023 - abcheartfailure.org
Endomyocardial fibrosis (EMF) is a restrictive cardiomyopathy of unknown origin, affecting
mainly young people from tropical countries. EMF is considered to be the most restrictive …
mainly young people from tropical countries. EMF is considered to be the most restrictive …
Endomyocardial fibrosis: diagnosis and management
SI Khalil - Journal of Vascular Diagnostics and Interventions, 2020 - Taylor & Francis
Introduction: Endomyocardial fibrosis (EMF) is a form of restrictive cardiomyopathy of
unknown etiology, characterized by endocardial fibrosis of the apices and inflow tracts of the …
unknown etiology, characterized by endocardial fibrosis of the apices and inflow tracts of the …
Republished: recent advances in the epidemiology, diagnosis and treatment of endomyocardial fibrosis in Africa
AOH Mocumbi, AO Falase - Postgraduate Medical Journal, 2014 - academic.oup.com
Endomyocardial fibrosis (EMF) continues to be an important and disabling disease in many
parts of Africa, although its prevalence has declined in some parts of the continent …
parts of Africa, although its prevalence has declined in some parts of the continent …
The changing pattern of endomyocardial fibrosis in South-west Nigeria
PO Akinwusi, AO Odeyemi - Clinical Medicine Insights …, 2012 - journals.sagepub.com
Background Endomyocardial fibrosis (EMF) is a restrictive cardiomyopathy, the prevalence
of which is declining globally. This study was carried out to determine if there were changing …
of which is declining globally. This study was carried out to determine if there were changing …
Endomyocardial fibrosis: Seven decades later in the Nigerian setting
GC Isiguzo, O Micheal, JA Onuh… - Nigerian Journal of …, 2015 - journals.lww.com
Background: Endomyocardial fibrosis (EMF), an obliterative cardiomyopathy of uncertain
etiology, is the most common restrictive cardiomyopathy worldwide with no specific …
etiology, is the most common restrictive cardiomyopathy worldwide with no specific …
Endomyocardial fibrosis: past, present, and future
AR Duraes, Y de Souza Lima Bitar, L Roever… - Heart failure …, 2020 - Springer
Endomyocardial fibrosis (EMF) is a neglected idiopathic disorder, predominant in tropical
and subtropical regions of the developing world. It is characterized by fibrotic thickening of …
and subtropical regions of the developing world. It is characterized by fibrotic thickening of …
Recent advances in the epidemiology, diagnosis and treatment of endomyocardial fibrosis in Africa
AOH Mocumbi, AO Falase - Heart, 2013 - heart.bmj.com
Endomyocardial fibrosis (EMF) continues to be an important and disabling disease in many
parts of Africa, although its prevalence has declined in some parts of the continent …
parts of Africa, although its prevalence has declined in some parts of the continent …
Left ventricle endomyocardial fibrosis: a case report
RR Soares, MCM Avelar, SL Zanetti… - Journal of Medical Case …, 2023 - Springer
Background Endomyocardial fibrosis is a grim disease. It is the most common restrictive
cardiomyopathy worldwide, but the exact etiology and pathogenesis both remain unknown …
cardiomyopathy worldwide, but the exact etiology and pathogenesis both remain unknown …